OXYINK

Oxyband Technologies, Inc.

Application Filed: 2016-08-12

Trademark Application Details

Status

604

Dead/Abandoned

ABANDONED - AFTER INTER-PARTES DECISION

Research	OneLook Acronym Finder
Serial Number	87137208
Mark Drawing Code	4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Attorney Docket Number	4449 TM
Law Office Assigned	L20
Employee Name	RINKER, ANTHONY MICHAE

Timeline

2016-08-12	Application Filed
2017-06-06	Published for Opposition
2017-09-26	Abandon
2017-09-26	Location: TTAB
2017-09-26	Status: Dead/Abandoned
2018-07-08	Transaction Date

Trademark Applicants & Owners

Owner:	OXYBAND TECHNOLOGIES, INC.
Address	10440 Trenton Avenue St Louis DE 63132
Legal Entity Type	Corporation
Legal Entity State	DE

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

OXYBAND TECHNOLOGIES INC
10440 TRENTON AVENUE
ST LOUIS, MO 63132

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	Antibiotic creams; Antibiotic ointments; Antibiotic preparations; Antifungal creams for medical use; Antifungal preparations; Antimicrobial preparations for treating combat battle field wounds; Antimicrobials for dermatologic use; Oxygen for medical purposes; Oxygen for medical use; Pain relief medication; Wound dressings; Adhesive for bandages for skin wounds; Adhesive for bandages for skin wounds; Bandages for skin wounds; Bandages for skin wounds; Biological tissue cultures for medical purposes; Biological tissue grafts; Biostatic antimicrobial preparations for treating bacteria, mold, mildew, algae and yeast and for inhibiting growth of those organisms; Dressings for combat battle field wounds; Gene therapy products, namely, genetically engineered tissues for transplant purposes; Hemostatic gel matrix preparations for treating wounds; Human allograft tissue; Implantable scaffolds comprising living tissue for maintaining tissue contour; Implants comprising living tissue; Medical adhesives for binding wounds; Medicaments for recovery of combat battle field wounds; Medicated skin care preparations; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels; Medicinal creams for skin care; Mixed antibiotic preparations; Molecular complex for the delivery of non-radical oxygen for medicinal, surgical, therapeutic or veterinary purposes; Natural biomaterials for augmentation of bone and tissue for medical purposes; Pharmaceutical skin lotions; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for skin care; Pharmaceutical preparations for wounds; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for treating skin disorders; Processed human donor skin for the replacement of soft tissue; Processed human donor skin for the replacement of soft tissue; Surgical implants comprised of living tissues; Surgical implants comprising living tissue; Surgical mesh comprised primarily of living tissue; Therapeutic agents for delivery of oxygen to human tissue; Therapeutic agents for delivery of oxygen to human tissue; Vascular grafts; silver iodide for medical purposes

Type Code

Type

GS0051

Antibiotic creams; Antibiotic ointments; Antibiotic preparations; Antifungal creams for medical use; Antifungal preparations; Antimicrobial preparations for treating combat battle field wounds; Antimicrobials for dermatologic use; Oxygen for medical purposes; Oxygen for medical use; Pain relief medication; Wound dressings; Adhesive for bandages for skin wounds; Adhesive for bandages for skin wounds; Bandages for skin wounds; Bandages for skin wounds; Biological tissue cultures for medical purposes; Biological tissue grafts; Biostatic antimicrobial preparations for treating bacteria, mold, mildew, algae and yeast and for inhibiting growth of those organisms; Dressings for combat battle field wounds; Gene therapy products, namely, genetically engineered tissues for transplant purposes; Hemostatic gel matrix preparations for treating wounds; Human allograft tissue; Implantable scaffolds comprising living tissue for maintaining tissue contour; Implants comprising living tissue; Medical adhesives for binding wounds; Medicaments for recovery of combat battle field wounds; Medicated skin care preparations; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels; Medicinal creams for skin care; Mixed antibiotic preparations; Molecular complex for the delivery of non-radical oxygen for medicinal, surgical, therapeutic or veterinary purposes; Natural biomaterials for augmentation of bone and tissue for medical purposes; Pharmaceutical skin lotions; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for skin care; Pharmaceutical preparations for wounds; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for treating skin disorders; Processed human donor skin for the replacement of soft tissue; Processed human donor skin for the replacement of soft tissue; Surgical implants comprised of living tissues; Surgical implants comprising living tissue; Surgical mesh comprised primarily of living tissue; Therapeutic agents for delivery of oxygen to human tissue; Therapeutic agents for delivery of oxygen to human tissue; Vascular grafts; silver iodide for medical purposes

Trademark Filing History

Description	Date	Event Coding
NEW APPLICATION ENTERED IN TRAM	2016-08-16	1 NWAP I:Incoming Correspondence
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2016-08-18	2 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER	2016-09-21	3 DOCK D:Assigned to Examiner
NON-FINAL ACTION WRITTEN	2016-09-28	4 CNRT R:Renewal
NON-FINAL ACTION E-MAILED	2016-09-28	5 GNRT F:First Action
NOTIFICATION OF NON-FINAL ACTION E-MAILED	2016-09-28	6 GNRN O:Outgoing Correspondence
EXAMINERS AMENDMENT -WRITTEN	2017-04-26	7 CNEA R:Renewal
EXAMINERS AMENDMENT E-MAILED	2017-04-26	8 GNEA O:Outgoing Correspondence
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED	2017-04-26	9 GNEN O:Outgoing Correspondence
EXAMINER'S AMENDMENT ENTERED	2017-04-26	10 XAEC I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER	2017-04-26	11 CNSA P:
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	2017-05-17	12 NONP E:E-Mail
PUBLISHED FOR OPPOSITION	2017-06-06	13 PUBO A:Allowance for Publication
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	2017-06-06	14 NPUB E:E-Mail
OPPOSITION PAPERS RECEIVED AT TTAB	2017-06-09	15 OPPF T:TTAB Proceeding
OPPOSITION INSTITUTED NO. 999999	2017-06-09	16 OP.I T:TTAB Proceeding
OPPOSITION SUSTAINED NO. 999999	2017-09-26	17 OP.S T:TTAB Proceeding
OPPOSITION TERMINATED NO. 999999	2017-09-26	18 OP.T T:TTAB Proceeding
ABANDONMENT - AFTER INTER PARTES DECISION	2017-09-26	19 ABN4 O:Outgoing Correspondence
ABANDONMENT NOTICE MAILED - INTER PARTES DECISION	2017-09-26	20 MAB4 O:Outgoing Correspondence

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
OXYINK 87561026 not registered Dead/Abandoned	OXYBAND TECHNOLOGIES, INC. 2017-08-08
OXYINK 87137208 not registered Dead/Abandoned	OXYBAND TECHNOLOGIES, INC. 2016-08-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.